Viewing StudyNCT01604031



Ignite Creation Date: 2024-05-06 @ 12:32 AM
Last Modification Date: 2024-10-26 @ 10:51 AM
Study NCT ID: NCT01604031
Status: TERMINATED
Last Update Posted: 2016-02-08
First Post: 2012-05-04

Brief Title: Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells Lenalidomide
Sponsor: Baylor College of Medicine
Organization: Baylor College of Medicine

Organization Data

Organization: Baylor College of Medicine
Class: OTHER
Study ID: H-30087 TAIL
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Baylor College of Medicine
Lead Sponsor Class: OTHER
Responsible Party: Martha Mims
Responsible Party Title: Associate Professor
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Baylor College of Medicine
Old Name: None
Old Organization: None

Collaborators

Name Class
The Methodist Hospital Research Institute OTHER
Center for Cell and Gene Therapy Baylor College of Medicine OTHER